Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Faith Leaders Advocating for Maternal Empowerment (FLAME)

Not Applicable

Completed

Conditions: Maternal Health Services
Prenatal Care
Perinatal Care

Interventions: Behavioral: FLAME

First Posted Date: 2019-07-31

Last Posted Date: 2021-10-27

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT04039932

Locations: 🇪🇹
University of Gondar, Gondar, Amhara, Ethiopia

Guiding Good Choices for Health

Not Applicable

Active, not recruiting

Conditions: Adolescent Substance Use

Interventions: Behavioral: Guiding Good Choices

First Posted Date: 2019-07-31

Last Posted Date: 2024-06-03

Lead Sponsor: University of Washington

Target Recruit Count: 3636

Registration Number: NCT04040153

Locations: 🇺🇸
Kaiser Permanente Northern California, Oakland, California, United States
🇺🇸
Kaiser Permanente Colorado, Aurora, Colorado, United States
🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

The PrEP (Pre-exposure Prophylaxis) SMART Study

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: WhatsApp Group
Behavioral: 2-way SMS
Behavioral: Drug level feedback
Behavioral: Monthly counseling sessions

First Posted Date: 2019-07-30

Last Posted Date: 2023-09-01

Lead Sponsor: University of Washington

Target Recruit Count: 350

Registration Number: NCT04038060

Locations: 🇿🇦
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa

Motivating Campus Change Study

Not Applicable

Active, not recruiting

Conditions: Drinking Behavior

Interventions: Behavioral: Sequential Personalized Feedback Intervention Delivery
Behavioral: Simultaneous Personalized Feedback Intervention Delivery
Behavioral: Text Message Boosters

First Posted Date: 2019-07-23

Last Posted Date: 2024-12-12

Lead Sponsor: University of Washington

Target Recruit Count: 1012

Registration Number: NCT04030325

Locations: 🇺🇸
The Center for the Study of Health and Risk Behaviors, Seattle, Washington, United States

The Deliver Health Study

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Other: Fee based delivery

First Posted Date: 2019-07-19

Last Posted Date: 2022-03-04

Lead Sponsor: University of Washington

Target Recruit Count: 162

Registration Number: NCT04027153

Locations: 🇿🇦
HSRC Sweetwaters, Sweetwaters, Kwa-Zulu Natal, South Africa

BPO vs Hibiclens Soap for Surgical Preparation

Phase 4

Completed

Conditions: Propionibacterium Acnes

Interventions: Drug: Benzoyl Peroxide 10% Bar
Drug: Chlorhexidine Gluconate

First Posted Date: 2019-07-16

Last Posted Date: 2022-03-15

Lead Sponsor: University of Washington

Target Recruit Count: 50

Registration Number: NCT04021524

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Online Prenatal Trial in Mindfulness Sleep Management

Not Applicable

Completed

Conditions: Insomnia
Depression
Pregnancy Related

Interventions: Behavioral: OPTIMISM
Behavioral: Sleep Education

First Posted Date: 2019-07-11

Last Posted Date: 2022-07-05

Lead Sponsor: University of Washington

Target Recruit Count: 64

Registration Number: NCT04016428

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer

Phase 2

Terminated

Conditions: Castration-Resistant Prostate Carcinoma
Double-Negative Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions: Drug: Abiraterone Acetate
Drug: Enzalutamide
Drug: Erdafitinib

First Posted Date: 2019-06-26

Last Posted Date: 2023-09-28

Lead Sponsor: University of Washington

Target Recruit Count: 3

Registration Number: NCT03999515

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Veterans Nature Therapy (Vet Hike)

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorders

Interventions: Behavioral: Group urban hikes
Behavioral: Group nature hikes

First Posted Date: 2019-06-25

Last Posted Date: 2021-06-14

Lead Sponsor: University of Washington

Target Recruit Count: 26

Registration Number: NCT03997344

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1

Completed

Conditions: Recurrent B Acute Lymphoblastic Leukemia
Refractory B Lymphoblastic Lymphoma
Recurrent B Lymphoblastic Lymphoma
Refractory B Acute Lymphoblastic Leukemia

Interventions: Drug: Etoposide
Drug: Doxorubicin
Drug: Vincristine
Drug: Prednisone
Drug: Cyclophosphamide
Biological: Inotuzumab Ozogamicin

First Posted Date: 2019-06-19

Last Posted Date: 2023-07-06

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT03991884

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy